Glucagon Receptor Antagonist I – 1 mg

Brand:
Cayman
CAS:
438618-32-7
Storage:
-80
UN-No:
Non-Hazardous - /

Glucagon receptor antagonist I is a competitive antagonist of the glucagon receptor (GCGR; IC50 = 181 nM).{33305} It blocks glucagon-induced glycogenolysis in primary human hepatocytes and isolated liver.{33305} Glucagon receptor antagonist I, at 50 mg/kg, reduces the increase in glucose levels observed after intraperitoneal administration of glucagon in humanized mice.{33305} Glucagon receptor antagonist inactive control (Item No. 21188) does not prevent glucagon-mediated actions.{33305}  

 

Out of stock

SKU: 21223 - Category:

Description

A competitive antagonist of GCGR (IC50 = 181 nM); blocks glucagon-induced glycogenolysis in primary human hepatocytes, isolated liver, and humanized mice


Formal name: N-[3-cyano-6-(1,1-dimethylpropyl)-4,5,6,7-tetrahydrobenzo[b]thien-2-yl]-2-ethyl-butanamide

Synonyms:  GCGR Antagonist I

Molecular weight: 346.5

CAS: 438618-32-7

Purity: ≥99%

Formulation: A crystalline solid


Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Endocrinology & Metabolism|Carbohydrate Metabolism